Mitochondria-targeted antioxidants such as MitoQ, SkQ1, and SS-31 have been developed to selectively scavenge mitochondrial ROS, thereby protecting mtDNA from oxidative lesions and preventing inflammatory activation [204]
These symptoms are often temporary and improve as the body adjusts.* Medical Monitoring Recommended: Regular follow-up with your healthcare provider is important to monitor progress, evaluate tolerance, and optimize your wellness plan while using GLP-1/GIP therapy.* Not Appropriate for Everyone: GLP-1/GIP therapy may not be suitable for individuals with certain medical conditions including a history of medullary thyroid carcinoma, MEN2 syndrome, pancreatitis, or severe gastrointestinal disorders
Human thyroxine-binding globulin (TBG) promoter directs efficient and sustaining transgene expression in liver-specific pattern
LCMS/MS Detection Quantification occurs using targeted tandem mass spectrometry (MS/MS) with multiple reaction monitoring and stable isotope internal standards
Adjunctive low-dose docosahexaenoic acid (DHA) for major depression: an open-label pilot trial
